- Agentic AI Strategic Intelligence Research Report 2025: Expansive Opportunities by Enabling Autonomous Decision-making, Especially in Complex Environments
Sep 22, 2025
Dublin, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Agentic AI" report has been added to ResearchAndMarkets.com's offering.
This report provides analysis of this emerging AI technology, including an overview of how AI agents work, guidance on how enterprises can implement agentic AI, and agentic AI use cases by industry.
Able to communicate and collaborate, AI agents are being developed for various consumer, enterprise, scientific, and industrial purposes. Highly complex environments, such as industrial plants or hospitals, might be served by multiple AI agents, each with a different purpose. According to a June 2024 Capgemini survey of 1,100 large enterprises, one in 10 organizations is deploying AI agents, with more than 50% planning to explore their use in the next year.
Leading tech companies are building upon existing AI assistants by creating platforms and tools to support developers. Specialist development companies are emerging with the expertise to work with large language models (LLMs) and the various machine learning models needed to implement AI agents. Agentic AI is expected to shape the future of DevOps (the set of practices around software integration and delivery).
Combined with the ability to interact with both LLMs and the external environment, AI agents are empowered to execute more general-purpose work. Retrieval-augmented generation (RAG) is a design approach that aims to make LLMs more reliable by automatically retrieving information from external knowledge bases. It can ensure more accurate and contextually relevant outputs.
Scope
Agentic AI refers to advanced AI systems that act autonomously, making decisions and taking actions with limited or no human supervision. An AI agent is a software program that interacts with its environment, collecting data to perform specific tasks, answer questions, and automate processes for users.
Reasons to Buy
Although it is still early days for agentic AI, initial best practices are starting to emerge that can help enterprises that choose to develop their own agentic AI strategies or collaborate with agentic AI vendors. This report includes simple but essential steps that will help to streamline the creation and adoption of agentic AI into existing processes.
Key Topics Covered:
Executive SummaryAgentic AI: The Journey BeginsHow Do AI Agents Work?An Evolving EcosystemHow Enterprises Can Implement Agentic AIAgentic AI Use Cases by IndustryCase StudiesChallenges for the FutureGlossaryFurther Reading
Companies Featured
AdaAdept.aiAffineonAgenttechAIQAmazonAMDAnteriorAnthropicAvantiaAutomation AnywhereAWSAxanol AIBizdataBoosted.aiChatDevCiscoCohereComposableConcourseConnex AIContext.aiCounterpartCrew.aiDatabricksDataRobotDeepSeekDevinitiDideroElasticEmaEricssonFinnomenaFourkitesGhostwriterGoogleGretelH CompanyHappyRobotHarveyHCL TechHSO.aiHarnessHippocratic.aiIBMIndemIndico DataInnovaccerIntuitK HealthLangChainLegoraLuminanceLumberKanerikaMaisaMetaMetaGPTMcGillMicrosoftMistralNASANetdocumentNeutrinosNokiaNorm AINvidiaNucliaOpen AIOpticaOraclePandoPerplexityProcoreProject 44RapidminerRelevance AISalesforceSASServicenowShopsenseSpellbookSynthpopSysdigTalkdeskThoughtful.aiToyotaTwin KnowledgeTrunk ToolsUniversity of ZurichVercelVidaVstromZapier
For more information about this report visit https://www.researchandmarkets.com/r/qk7pb2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- 3 Sectors Set to Soar in the Second Half of 2023
Jun 12, 2023
There are two key trends I expect to see in the second half of 2023. One, increased consumer spending on physical products, and two, continued AI proliferation. The three high-growth sectors I’ll profile in this column are poised to benefit from these trends.
Notably, the trend of increased spending on physical products was, I believe, foreshadowed by macroeconomic data released on June 5. On that day, the Institute for Supply Management reported a decline in non-manufacturing PMI from 51.9 in April to 50.3 last month.
Meanwhile, “orders for non-defense capital goods excluding aircraft rose 1.3% in April,” coming on the heels of a 1.4% increase in the same metric in March. The gains suggest US factories are gearing up to increase output of consumer goods in anticipation of rising demand in H2 2023. Thus, analysts and companies indicate that demand for consumer electronics has likely bottomed and will rebound in the second half.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Of course, AI’s tremendous power has taken the business world and consumers by storm and will continue to do so.
With that said, here are my three top sectors for investment for the second half of 2023.
E-Commerce e-commerce stocks
Source: Shutterstock
E-commerce will benefit from increased consumer buying activity in the second half of this year.
Why? Well, the sector is poised to get a big boost from the proliferation of AI. The technology will boost e-commerce revenue by targeting consumers with personalized ads and product suggestions. Additionally, the technology will reduce costs for suppliers, enabling e-commerce firms to offer better prices, increasing profits along the way.
Investors will see e-commerce companies benefit from autonomous vehicles, drones, and robots enabled by AI. What’s more, the repetitive routes that e-commerce companies utilize are tailor-made for autonomous vehicles. Experts have highlighted significant demand for autonomous trucks in optimizing supply chains and reducing delivery expenses.
Accordingly, among my favorite e-commerce stocks to buy right now are Amazon (NASDAQ:AMZN), Coupang (NYSE:CPNG), and JD.com (NASDAQ:JD).
Robotics a computer rendering of Miso Robotics's "Flippy" robot
Source: Miso Robotics
I believe that, as excitement over the capabilities of AI greatly increases, the utilization of AI-powered robotics will surge. Increased AI investments will enhance robot capabilities, driving higher adoption and utilization across firms. These trends should start becoming evident in the second half of the year. As a result, I believe that robotics is one of the top high-growth sectors in which to invest at this point.
Already, many more industries are starting to utilize robots than in the past, with health care, aerospace, and even food and beverage firms using robots on a wider scale. Tech giants like Amazon and Tesla (NASDAQ:TSLA) are leading the way with widespread robot usage, inspiring other firms to follow suit.
Indeed, according to Investopedia, “market research analysts have forecast the robotics market will expand to $214.7 billion by 2030, growing at a compound annual growth rate (CAGR) of almost 23%.1.”
Currently, some of my favorite picks in the robotics space are ABB (NYSE:ABB) and Nuance Communications (NASDAQ:NUAN).
Semiconductors semiconductor stocks Close-up electronic circuit board. technology style concept. representing semiconductor stocks
Source: Shutterstock
Semiconductor, or chip, makers have a wide range of massive, positive catalysts going forward. Among these catalysts are the huge demand for chips needed to create AI systems, and tremendous increases in the amount of chips used in automobiles.
Further, on the AI front, data centers are going to need to utilize more chips in order to generate the computing power and network bandwidth that are required to process AI workloads.
Indeed, many chip makers beyond Wall Street’s favorite name in the sector, Nvidia (NASDAQ:NVDA), are going to benefit from these strong trends. For example, Qualcomm’s (NASDAQ:QCOM) chips appear to have more “power efficiency” than those of Nvidia. Consequently, Qualcomm’s offerings are well-positioned to be used to power AI systems after they’re launched.
Moreover, Applied Materials (NASDAQ:AMAT), whose equipment is used to make chips, is going to get a big lift from surges in the sheer number of chips needed to create and power AI systems and automobiles.
Finally, Intel ‘s (NASDAQ:INTC) chips appear to be well-suited for generating “some AI capabilities,” while the company appears to be poised to manufacture many chips for Nvidia.
Accordingly, given the proliferation of the Internet of Things and artificial intelligence, these stocks are likely to continue to surge higher from here.
As of the date of publication, Larry Ramer owned shares of INTC. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Larry Ramer has conducted research and written articles on U.S. stocks for 15 years. He has been employed by The Fly and Israel’s largest business newspaper, Globes. Larry began writing columns for InvestorPlace in 2015. Among his highly successful, contrarian picks have been PLUG, XOM and solar stocks. You can reach him on Stocktwits at @larryramer.
More From InvestorPlace
Buy This $5 Stock BEFORE This Apple Project Goes Live Did Elon Musk Just Trigger a New Netscape Moment? The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Sectors Set to Soar in the Second Half of 2023 appeared first on InvestorPlace.
- Microsoft subsidiary Nuance is using GPT-4 for a new physician notes app
Mar 20, 2023 · geekwire.com
Microsoft-owned AI company Nuance is leveraging GPT-4 to power new software designed to ease the burden of clinical documentation for physicians.
- Court dismisses former employee’s retaliation case against Nuance
Jul 26, 2022
A Florida federal judge has thrown out a lawsuit brought against Nuance Communications Inc. by a former employee, dismissing the software engineer's claim that the company retaliated against him for identifying and disclosing a cybersecurity breach.
- Nuance Named Leader in Opus Research 2022 Enterprise-Scale Conversational AI Ranking
May 26, 2022
Recognized as "Best in Class", Nuance Earns Highest Vendor Score for Product Completeness and Flexibility
BURLINGTON, Mass., May 26, 2022 /PRNewswire/ -- Nuance® Communications, Inc. today announced it was recognized as a Leader in Opus Research's 2022 Decision Makers' Guide to Enterprise Intelligent Assistants report. The report cites Nuance's holistic approach as well as its growing ecosystem of partners and industry collaborators, naming the company's technology a "Best in Class Intelligent Assistant Platform" and giving it the highest assessment amongst its peers for "completeness of services, features, and scaling capabilities."
The Opus report evaluated 21 vendors to better understand enabling platforms and technology, integration points and scalability, and track record and future vision for enterprise-scale conversational AI. In its evaluation, the firm emphasized natural user interface, focus on customer outcomes, and flexible tooling that spans "no-code/low-code" as well as "pro-code" approaches.
"Our evaluation zeroed in on solution providers that take an approach that employs AI to augment human intelligence and vice versa when deploying intelligent assistants," said Derek Top, Senior Analyst and Research Director, Opus Research. "Nuance's technology provides not only the flexible, cloud-native tools and workflows needed to create customer-facing conversational AI solutions but also meets the growing need of supporting customer care agents in real-time conversations. Nuance has a comprehensive set of features and the ability to scale at an enterprise level."
The report highlights the increasing enterprise demand for flexible tools that can address the expanding set of use cases between conversational apps, contact centers, knowledge centers and data repositories. It recognizes Nuance's open approach and notes Nuance's "orchestrated, AI-infused Intelligent Assistant development and management, and use of native technologies that support both agent assist and customer assistance."
Story continues
"I'm proud of the team for earning this impressive achievement five years in a row," said Tony Lorentzen, Senior Vice President of Intelligent Engagement Solutions, Nuance. "This ranking demonstrates how we innovate with and for our customers, investing in the areas that are crucial to augmenting consumer and agent experiences, improving ROIs, and offering flexible, personalized, and secure ways to power digital self-service."
Offering a range of options from custom builds to cloud-native tools, Nuance's AI-powered omni-channel engagement solutions are trusted by 85% of the Fortune 100. Empowered to prevent fraud and deliver superior customer experiences, customers using Nuance have reported an 88% increase in first-contact resolution, 20% increase in agent and employee satisfaction and 50% increase in CSAT.
To download the full Opus Research 2022 Decision Makers' Guide to Intelligent Assistants report, go here.
For more information on Nuance's AI-powered omni-channel engagement solutions, go here: https://www.nuance.com/omni-channel-customer-engagement.html.
About Nuance Communications, Inc. Nuance Communications is a technology pioneer with market leadership in conversational AI and ambient intelligence. A full-service partner trusted by 77 percent of U.S. hospitals and 85 percent of the Fortune 100 companies worldwide, Nuance creates intuitive solutions that amplify people's ability to help others. Nuance is a Microsoft company.
Contact Information
Nuance Communications
Dayna McCoubrey
+1 781.565.4728
Dayna.McCoubrey@nuance.com Nuance Communications, Inc. logo (PRNewsfoto/Nuance Communications, Inc.) Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuance-named-leader-in-opus-research-2022-enterprise-scale-conversational-ai-ranking-301555553.html
SOURCE Nuance Communications, Inc.
- Demand for Global Healthcare CRM Market Size & Share Will Grow at a CAGR of 13.7%, Expected to Hit USD 22073.1 Million by 2028 | Industry Trends, Revenue Analysis & Forecast Report by Facts & Factors
Apr 27, 2022
LONDON, UK, April 27, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Healthcare CRM Market By Components (Software, and Services), By Deployment Model (On-premise Model, the Web/Cloud-based Model), By Functionality (Customer Service and Support, Marketing, Sales, Digital Marketing, and Other Functionalities), By End-User (Healthcare Providers, Healthcare Payers, and Life Sciences Industry), and By Region - Global and Regional Industry Trends, Market Insights, Data analysis, Historical Information, and Forecast 2022–2028” in its research database.
“According to the latest research study, the demand of global Healthcare CRM Market size & share was worth around USD 10216.5 million in 2021 and is estimated to grow to about USD 22073.1 million by 2028, with a compound annual growth rate (CAGR) of approximately 13.7% over the forecast period 2022 to 2028.”
What is Healthcare CRM? How big is the Healthcare CRM Market?
Report Overview:
Healthcare CRM is used to acquire a massive amount of patient data from many sources. CRM solutions are rapidly being used by healthcare organizations to improve sales, services, and marketing activities, as well as to obtain a higher Return on investment (ROI). CRM technology enables the automation of tasks like communicating test results and sending emails and text messages. Cloud-based technology is used to maintain an efficient healthcare CRM, such as social CRM. The enormous increase in the healthcare industry around the world is one of the key factors creating a positive outlook for the market in the forecast period.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/healthcare-crm-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.The COVID-19 Pandemic Outbreak Impact Analysis is included in the packageAbout 205+ Pages Research Report (Including Recent Research)Provide detailed chapter-by-chapter guidance on RequestUpdated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022Includes Tables and figures have been updatedThe most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Facts and Factors research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Global Healthcare CRM Market: Dynamics
The rise in online product ordering, increased demand for customer relationship management software among pharmaceutical companies, and rapid digital transformation in developing countries such as the United States, Germany, and France are driving growth in the healthcare CRM market in the forecast period. In addition, the increased use of social media marketing for product promotion propels the growth of the healthcare CRM market in the coming years.
The rise in patient desire for a more convenient approach to treatments via virtual patient care, as well as the rise in technology developments in reconstructing healthcare databases, is projected to drive growth in the healthcare CRM industry. Furthermore, patients' increasing demand for early therapy through home care, digital care, portable surveillance, and illness monitoring devices will contribute to the growth of the healthcare CRM market. The rise in the number of chronic diseases like diabetes and cancer, which require rapid medical support and treatment, is expected to drive growth in the healthcare CRM market in the upcoming years.
Moreover, the rise in the adoption of the bring your own device (BYOD) ecosystem, as a result of the increased use of smartphones, as well as the high operational efficiency and low operational cost of healthcare CRM software, is expected to create lucrative opportunities in the healthcare CRM market in the approaching years. However, the lack of security regarding the privacy of consumer information, as well as the high initial installation cost of this software, limit the market's global expansion.
Directly Purchase a copy of the report with TOC @https://www.fnfresearch.com/buynow/su/healthcare-crm-market
Competitive Landscape
Some of the main competitors dominating the Healthcare CRM Market include;
Salesforce.com Inc. (US)SAP SE (Germany)Oracle (US)Microsoft (US)IBM (US)Influence Health (US)SugarCRM (US)Accenture (Ireland)Healthgrades (US)Infor Inc. (US)
Healthcare CRM Market: COVID-19 Impact Analysis
The pandemic of COVID-19 had a severe impact on healthcare facilities. An integrated solution to manage workflow and give appropriate aid and care to patients all over the world was in high demand. In light of shifting healthcare coverage requirements and the added burden of a potential pandemic, focusing on patient communication is extremely important. The utilisation of data, analytics, and digitalization technologies has had a huge impact on the healthcare IT industry. In response to the COVID-19 epidemic, some healthcare organisations created novel treatment strategies to deal with quickly rising patient populations.
Those at the forefront, who were plagued with out-of-date employee communication and patient engagement systems that couldn't scale, swiftly adopted digital solutions to keep up with the massive demands imposed on staff and clinical teams. COVID-19 has prompted industry participants to focus on R&D in order to improve and innovate in the Healthcare CRM market.
Key questions answered in this report:
What are the top five global Healthcare CRM players?How will the market look like in five years?What are the Healthcare CRM market's drivers and restraints?Which region's market will increase the most?What will the Healthcare CRM market's CAGR and size be during the forecast period?Which area offers the greatest benefit to the global market?What are the business risks, and how will the current situation affect growth and market perception?
Browse the full “Healthcare CRM Market By Components (Software, and Services), By Deployment Model (On-premise Model, the Web/Cloud-based Model), By Functionality (Customer Service and Support, Marketing, Sales, Digital Marketing, and Other Functionalities), By End-User (Healthcare Providers, Healthcare Payers, and Life Sciences Industry), and By Region - Global and Regional Industry Trends, Market Insights, Data analysis, Historical Information, and Forecast 2022–2028” Report at https://www.fnfresearch.com/healthcare-crm-market
Report Scope
Report AttributeDetailsMarket Size in 2021USD 10216.5 MillionProjected Market Size in 2028USD 22073.1 MillionCAGR Growth Rate13.7% CAGRBase Year2021Forecast Years2022-2028Key Market PlayersSalesforce.com, Inc. (US), SAP SE (Germany), Oracle (US), Microsoft (US), IBM (US), Influence Health (US), SugarCRM (US), Accenture (Ireland), Healthgrades (US), and Infor, Inc. (US)., and OthersKey SegmentBy Component, Deployment Model, Functionality, End-User, and By RegionMajor Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & AfricaPurchase OptionsRequest customized purchase options to meet your research needs.
Healthcare CRM Market: Segmentation Analysis
The Healthcare CRM Market is segregated based on component, deployment model, functionality, and end-user. Based on components, the global market is distinguished into Software, and Services. Based on the deployment model, the global market is distinguished into On-premise Model, the Web/Cloud-based Model. Based on functionality, the global market is distinguished into Customer Service and Support, Marketing, Sales, Digital Marketing, and Other Functionalities. Based on end-user, the global market is distinguished into Healthcare Providers, Healthcare Payers, and Life Sciences Industry.
Inquire before buying this Research Report - https://www.fnfresearch.com/inquiry/healthcare-crm-market
Regional Dominance:
North America dominated the market during the forecast period because of its huge pool of hospitals, established payers, and expanding healthcare CRM use. A significant number of hospitals can be located in the region, which would help the market's expansion. The global healthcare CRM industry presents a number of obstacles. The high level of competitiveness in the area is one of the most important development factors. The healthcare CRM market will see increased demand as the North American region's healthcare infrastructure evolves. Asia-Pacific is considered the fastest-growing region in the global health care industry due to investors' increased interest in investing in the business.
The market is also becoming increasingly worldwide, prompting these firms to open offices in emerging markets such as India. This increase in the number of hospitals would necessitate the installation of computerized records systems and/or other software to streamline processes, and would thus be ascribed to market growth. Nonetheless, emerging countries invest heavily in developing their own healthcare infrastructures. This initiative is projected to attract a large number of investors and accelerate the development of the country's industry.
Recent Developments:
In 2021, Salesforce, a worldwide CRM leader, has introduced Vaccine Cloud, a solution that will assist government agencies, healthcare organizations, corporations, nonprofits, and educational institutions in more promptly, safely, and efficiently deploying and managing vaccine programs.In 2021, Nuance Communications, Inc. (NASDAQ: NUAN) introduced an AI-powered virtual assistant platform for patient engagement to transform voice and digital experiences throughout the patient journey. Nuance's platform integrates and expands the capabilities of a healthcare organization's important clinical, financial, customer, and telephony systems, such as the EHR, Patient Financial systems, CRM, and patient access center (call center) telephone infrastructure.
Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/healthcare-crm-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
This report segments the global healthcare CRM market as follows:
By Component
SoftwareServices
By Deployment Model
On-premise ModelWeb/Cloud-based Model
By Functionality
Customer Service and SupportMarketingSalesDigital MarketingOther Functionalities
By End-User
Healthcare ProvidersHealthcare PayersLife Sciences Industry
By Region
North America
U.S.CanadaRest of North AmericaEurope
FranceUKSpainGermanyItalyRest of EuropeAsia Pacific
ChinaJapanIndiaSouth KoreaRest of Asia PacificThe Middle East & Africa
Saudi ArabiaSouth AfricaRest of the Middle East & AfricaLatin America
BrazilArgentinaRest of Latin America
Key Insights from Primary Research:
As per the analysis shared by our primary respondents, the Healthcare CRM market is projected to grow at a CAGR of around 13.7%.Through the primary research, it was established that the Healthcare CRM market size was valued at around US$ 10216.5 million in 2021and is expected to surpass around US$ 22073.1 million by 2028.The necessity of ensuring customer happiness, growing emphasis on patient connection, and rising pressure on healthcare organizations to reduce costs are all major drivers driving the size of this industry.On the basis of region, the North America is likely to hold the highest share of the global healthcare CRM market during the forecast period due to the presence of well-established healthcare facilities and increased knowledge about healthcare IT solutions among hospitals and clinics in the region.
Request For Free Sample Report of the Global Healthcare CRM Market @https://www.fnfresearch.com/sample/healthcare-crm-market
Browse Other Related Research Reports from Facts & Factors:
Radiopharmaceutical Market By Type (Therapeutic and Diagnostic), By Application (Cardiology, Oncology, Neurology, and Others), By End-User (Diagnostic Centers, Hospitals & Clinics, and Others), and By Region-Global and Regional Industry Overview, Comprehensive Analysis, Competitive Intelligence, Statistical Evidence, and Forecast 2022–2028
Blood Pressure Monitoring Devices Market By Product (Ambulatory Blood Pressure Monitor, Digital Blood Pressure Monitor, Sphygmomanometer, Transducers, and Instruments & Accessories), By End-User (Home Healthcare, Hospitals, Ambulatory Surgical Centers & Clinics), and By Region-Global and Regional Market Dynamics, Data Analytics, Consumer Demand, Statistical Surveys, Extensive Research, Historical Trends, Current Patterns, and Forecast 2022–2028
Anti-Neoplastic Agents Market By Type of Product (Biological Agents, Personalized Medicine, and Chemotherapeutic Agents), By End-User (Cancer Rehabilitation Centers, Clinics, Hospitals, and Ambulatory Surgical Centers), and By Region-Global and Regional Industry Overview, Market Insights, Holistic Investigation, Historical Information, and Forecast 2022–2028
Non-Insulin Therapies for Diabetes Market By Product Type (Oral & Injectable) and By Distributor (Retail Pharmacies, Hospital Pharmacy, Online Pharmacy, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2028
Telepathology Service Market By System (Hybrid, Static and Dynamic), By Implementation (Research, Education, Diagnosis and Other), and By End User (Diagnostic Centres and Pathology Clinics, Hospitals, Academic Institutes, Research Organisations, Pharmaceutical, and Biotechnology Firms): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2022 – 2028
Pain Management Therapeutics Market By Drug Class (Anesthetics, Anticonvulsant, NSAIDs, Anti-Migraine Drugs, Opioids, Antidepressant Drugs, Non-Narcotics, and Analgesics), By Indication (Cancer Pain, Arthritic Pain, Acute Appendicitis, Neuropathic Pain, Chronic Pain, Post-Operative Pain, Fibromyalgia, Migraine, Bone Fracture, Muscle Sprain/Strain, and Others), By Pain Type (Chronic Pain and Acute Pain), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us on Twitter: https://twitter.com/fnfresearch
Follow Us on Facebook: https://www.facebook.com/factsandfactors/
Contact Us:
Sanu Thomas
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 96043 17127
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com
Blog: https://www.fnfresearch.com/blog/
- 10 Favorite Stocks of Billionaire Izzy Englander
Apr 15, 2022
In this article, we discuss 10 favorite stocks of billionaire Izzy Englander. If you want to see more stock picks of the billionaire, go see 5 Favorite Stocks of Billionaire Izzy Englander.
Israel “Izzy” Englander is an American billionaire investor and the founder of Millennium Management, a hedge fund he established in 1989 with Ronald Shear. Izzy Englander is a New York University graduate, and he started his career with Kaufmann, Alsberg & Co., a Wall Street investment firm. Englander founded a floor brokerage house, I.A. Englander & Co., in 1997. Later, he established Jamie Securities Co. in 1985. His next venture was Millennium Management, which is a $196.7 billion hedge fund as of Q4 2021.
Millennium Management operates in America, Europe, and Asia, with its headquarters in New York. The hedge fund has more than 270 investment teams. Izzy Englander serves as the chairman, chief executive officer, and co-chief investment officer of Millennium. His fund controls assets under management of over $295 billion.
Izzy Englander’s Q4 portfolio concentrates its investments in the information technology, healthcare, finance, consumer discretionary, industrials, and communications sectors. The hedge fund’s top 10 stocks comprise 18.65% of the total 13F holdings. In Q4 2021, Millennium Management purchased 1186 new stocks and sold out of 1205 securities.
The billionaire’s most notable stocks in Q4 2021 include Amazon.com, Inc. (NASDAQ:AMZN), Microsoft Corporation (NASDAQ:MSFT), and Tesla, Inc. (NASDAQ:TSLA), among others discussed extensively below.
Our Methodology
We used the fourth quarter portfolio of Izzy Englander’s Millennium Management to select the billionaire’s top 10 stocks. 10 Favorite Stocks of Billionaire Izzy Englander
Israel Englander of Millennium Management
Favorite Stocks of Billionaire Izzy Englander
10. Wells Fargo & Company (NYSE:WFC)
Millennium Management’s Stake Value: $361,694,000
Percentage of Millennium Management’s 13F Portfolio: 0.18%
Number of Hedge Fund Holders: 94
Story continues
Wells Fargo & Company (NYSE:WFC) is an American multinational financial services company that operates via its core subsidiary, the Delaware-based Wells Fargo Bank. Citi analyst Keith Horowitz on April 11 upgraded Wells Fargo & Company (NYSE:WFC) to Buy from Neutral.
In the fourth quarter of 2021, Izzy Englander’s Millennium Management held 7.5 million shares of Wells Fargo & Company (NYSE:WFC), worth $361.6 million, representing 0.18% of the hedge fund’s total 13F securities. Millennium increased its stake in the company by 452% in Q4 2021.
Wells Fargo & Company (NYSE:WFC) reported earnings for the first quarter of 2022, posting an EPS of $0.88, beating market consensus estimates by $0.07. Revenue over the period dropped 2.61% from the prior-year quarter, reaching $17.59 billion, falling short of analysts’ predictions by $232.38 million. The stock dropped when the company disclosed reduced share repurchases in the second quarter of 2022, and the inflationary pressures on operational expenditure.
According to Insider Monkey’s Q4 database, 94 hedge funds held Wells Fargo & Company (NYSE:WFC) in their public stock portfolios, up from 88 funds in the third quarter. The total stakes owned in the fourth quarter amounted to more than $6 billion. Boykin Curry’s Eagle Capital Management is the leading shareholder of the company, with over 20 million shares worth $961.4 million.
In addition to Amazon.com, Inc. (NASDAQ:AMZN), Microsoft Corporation (NASDAQ:MSFT), and Tesla, Inc. (NASDAQ:TSLA), Wells Fargo & Company (NYSE:WFC) is one of the top favorite stocks of Izzy Englander.
Here is what Davis Opportunity Fund has to say about Wells Fargo & Company (NYSE:WFC) in its Q4 2021 investor letter:
“The absolute level of revenues and profits generated by such companies is in fact so large that most of the major financial holdings in the portfolio produce enough annual operating income individually that a number of them could, in theory, purchase several entire businesses among hundreds of choices within the S&P 1500 Index, using just a year’s cash earnings without dipping into capital. This is theoretical, as financial companies would not be in the business of buying healthcare or technology companies, for example, but we point out these facts to illustrate the sheer scale of the economics produced by single financial companies in a given year, which is often a multiple of the cash earnings yielded by companies in a host of other industries.
Given this cash-generation power, we are naturally drawn to what we believe are strong and profitable financial institutions when the price is right. Presently, we believe the valuations of our financial holdings are not only reasonable, but extremely compelling, and our portfolio composition reflects this view. Representative financial holdings in the Fund include Wells Fargo.”
9. Nuance Communications, Inc. (NASDAQ:NUAN)
Millennium Management’s Stake Value: $362,022,000
Percentage of Millennium Management’s 13F Portfolio: 0.18%
Number of Hedge Fund Holders: 55
Nuance Communications, Inc. (NASDAQ:NUAN) is an American multinational computer software company that specializes in AI-powered speech synthesis and speech recognition applications. Nuance Communications, Inc. (NASDAQ:NUAN) was acquired by Microsoft Corporation (NASDAQ:MSFT) and operates as its subsidiary as of March 4, 2022.
The securities filings for Q4 2021 reveal that Izzy Englander’s Millennium Management owns 6.5 million shares of Nuance Communications, Inc. (NASDAQ:NUAN), worth $362 million, representing 0.18% of the fund’s total 13F holdings.
Nuance Communications, Inc. (NASDAQ:NUAN) was purchased by Microsoft for approximately $20 billion, or $56 per share in an all-cash transaction. The company has now stopped trading at the Nasdaq.
According to Insider Monkey’s fourth quarter database, 55 hedge funds were bullish on Nuance Communications, Inc. (NASDAQ:NUAN), with collective stakes amounting to $4.6 billion, compared to 61 funds in the prior quarter, holding stakes in the company worth $4.8 billion. Matthew Halbower’s Pentwater Capital Management is the biggest position holder in the company, with 17.34 million shares worth $959.2 million.
Here is what Rhizome Partners has to say about Nuance Communications, Inc. (NASDAQ:NUAN) in its Q3 2021 investor letter:
“We also exited our small position in Nuance upon Microsoft’s acquisition. Nuance is a leader in voice recognition software, with dominant market share, and its speech-to-text product is the gold standard in radiology. In addition, by eliminating the need for note taking and allowing doctors to focus on patient care, Nuance could transform the way doctors treat patients. We built a 1% position in Nuance after attending its comprehensive investor day. Our view is that if Nuance can successfully grow its voice-recognition software in doctor’s offices, it could be worth multiples of our cost basis. Microsoft’s acquisition eliminated the multi-bagger upside but also partially validates the belief that Nuance is a high-quality technology company. We exited Nuance with a 62% gain in less than a year. This example is representative of the slight adjustments we made to our portfolio construction. We will allocate to small bets on technology and high-growth companies that could increase our exposure to “right tail” upside. Rest assured that our focus is still roughly 50% real estate, 30% high-quality companies trading at cheap multiples of free cash flow, and the rest in investments with the potential for growth and higher upside.”
8. Alphabet Inc. (NASDAQ:GOOG)
Millennium Management’s Stake Value: $544,255,000
Percentage of Millennium Management’s 13F Portfolio: 0.27%
Number of Hedge Fund Holders: 158
Alphabet Inc. (NASDAQ:GOOG) has featured on Izzy Englander’s stock portfolio since the third quarter of 2015. Latest 13F filings reveal that Millennium Management held 188,090 shares of Alphabet Inc. (NASDAQ:GOOG) in the fourth quarter of 2021, worth $544.25 million, representing 0.27% of the fund’s total securities. Izzy Englander boosted his stake in the company by 28% in Q4.
Alphabet Inc. (NASDAQ:GOOG) posted solid financial results for Q4 on February 1, announcing earnings per share of $30.69, topping analysts' estimates by $3.41. The $75.33 billion revenue was up 32.39% year-over-year, exceeding market consensus by $3.50 billion.
On March 18, Tigress Financial analyst Ivan Feinseth maintained a Strong Buy rating on Alphabet Inc. (NASDAQ:GOOG) and raised the firm's price on the stock to $3,670 from $3,540. The analyst cited Alphabet Inc. (NASDAQ:GOOG)’s "extremely strong" Q4 results and its investment in AI, which "continues to drive increasingly focused and helpful experiences for users and businesses". Alphabet Inc. (NASDAQ:GOOG) is building its expertise in numerous segments, such as Search, mobile, cloud, data centers, e-commerce, entertainment, home automation, autonomous vehicles, and health and fitness, the analyst added.
Chris Hohn’s TCI Fund Management is the leading Alphabet Inc. (NASDAQ:GOOG) stakeholder as of Q4 2021, with approximately 3 million shares worth $8.5 billion. Overall, Alphabet Inc. (NASDAQ:GOOG) was found in the stock portfolios of 158 elite hedge funds tracked by Insider Monkey.
Here is what Vulcan Value Partners has to say about Alphabet Inc. (NASDAQ:GOOG) in its Q4 2021 investor letter:
“In contrast, we made a different kind of mistake about a decade ago. Google, now Alphabet, performed very well for us while we owned it. The company kept outperforming our assumptions and we kept lowering them to be conservative. “Trees do not grow to the sky.” The stock kept going up and our value grew but did not keep pace with the stock. It hit our estimate of fair value and we sold it with a nice gain, patting ourselves on the back. We kept following the company and what they actually did over the next several years was roughly double the assumptions we used to value it. Therefore, our value was too conservative, and we sold it too cheaply, missing many years of compounding. Fortunately, we experienced some volatility several years ago that allowed us to purchase Alphabet (Google) again with a margin of safety.”
7. Meta Platforms, Inc. (NASDAQ:FB)
Millennium Management’s Stake Value: $557,445,000
Percentage of Millennium Management’s 13F Portfolio: 0.28%
Number of Hedge Fund Holders: 224
Meta Platforms, Inc. (NASDAQ:FB) was incorporated in 2004 and is headquartered in Menlo Park, California. The company operates via two segments – Family of Apps and Reality Labs. Izzy Englander boosted his Meta Platforms, Inc. (NASDAQ:FB) stake by 81% in Q4 2021, holding shares worth $557.4 million, representing 0.28% of his fund’s total 13F portfolio.
In 2021, Meta Platforms, Inc. (NASDAQ:FB)’s revenue for the year stood at approximately $118 billion, up from $86 billion in the earlier year. The net income in 2021 came in at $39.3 billion, compared to $29.1 billion in 2020. Meta Platforms, Inc. (NASDAQ:FB) reported on April 13 that it will charge metaverse creators approximately 47.5% on sales of digital assets and 3D experiences created on the company’s VR platform, Horizon Worlds.
On April 14, Evercore ISI analyst Mark Mahaney added Meta Platforms, Inc. (NASDAQ:FB) to the firm's "TAP Underperform" list ahead of earnings from the large-cap Internet group. The analyst believes that Wall Street's revenue estimates for the first half of 2022 are "overly aggressive." He cited foreign exchange headwinds, possible brand ad spend pullback in Europe, and hard comps in the second quarter. However, he thinks that the second half of 2022 is attractive and he would buy Meta Platforms, Inc. (NASDAQ:FB) shares for the long run. The analyst reiterated an Outperform rating and a $350 price target on Meta Platforms, Inc. (NASDAQ:FB).
Hedge funds pulled back on Meta Platforms, Inc. (NASDAQ:FB) in the fourth quarter of 2021. According to Insider Monkey’s Q4 data, 224 hedge funds were long Meta Platforms, Inc. (NASDAQ:FB), down from 248 funds in the preceding quarter. Fisher Asset Management held a prominent stake in the company, with 9.5 million shares worth $3.2 billion.
Like Amazon.com, Inc. (NASDAQ:AMZN), Microsoft Corporation (NASDAQ:MSFT), and Tesla, Inc. (NASDAQ:TSLA), Meta Platforms, Inc. (NASDAQ:FB) is a notable stock in Izzy Englander’s Q4 portfolio.
Here is what Boyar Value Group has to say about Meta Platforms, Inc. (NASDAQ:FB) in its Q4 2021 investor letter:
“Corporate executives can have many different reasons for selling shares (anticipation of tax law changes, philanthropy, diversification, and much more), but the sheer number of billionaire founders who sold shares in 2021 should raise eyebrows and might well be signaling a market top. Bloomberg’s Ben Steverman and Scott Carpenter report not only that Mark Zuckerberg of Meta Platforms Inc. (formerly known as Facebook) sold shares in his company almost every day last year but also that the founders of Google sold ~$3.5 billion worth of stock (the first time either Sergey Brin or Larry Page has sold shares since 2017).”
6. AT&T Inc. (NYSE:T)
Millennium Management’s Stake Value: $662,163,000
Percentage of Millennium Management’s 13F Portfolio: 0.33%
Number of Hedge Fund Holders: 70
AT&T Inc. (NYSE:T) is a Texas-based multinational conglomerate that operates in the telecommunications and technology industries, specializing in satellite television, fixed-line telephones, mobile services, and internet services. Izzy Englander owned approximately 27 million AT&T Inc. (NYSE:T) shares in Q4 2021, worth more than $662 million.
In 2021, AT&T Inc. (NYSE:T)’s full-year revenue slid to $168.8 billion from $171.7 billion in 2020. The net income strongly rebounded in 2021, coming in at over $20 billion, compared to a net loss of $5.1 billion in the preceding year. The company’s cash and cash equivalents in 2021 increased to $21.2 billion from $9.7 billion in 2020.
On March 25, AT&T Inc. (NYSE:T) declared a $0.2775 per share quarterly dividend. The dividend is payable on May 2, to shareholders of the company as of April 14. AT&T Inc. (NYSE:T) is determined to remain a significant top yielding Fortune 500 company.
Raymond James analyst Frank Louthan on April 12 reiterated an Outperform rating on AT&T Inc. (NYSE:T) but lowered the firm's price target on the stock to $26 from $32 ahead of the Q1 results. While the analyst still sees a few challenges as smaller investors get in-line with the new dividend policy and the spinning out of shares in their accounts, he expects institutional interest to rise as the operations are less complex. With the Discovery deal eliminated, the analyst believes AT&T Inc. (NYSE:T) will be successful with its subscriber count growth in the future, due to a simplified marketing program.
According to Insider Monkey’s fourth quarter database, 60 hedge funds were long AT&T Inc. (NYSE:T), compared to 66 funds in the earlier quarter. The total stakes owned in Q4 amounted to roughly $5 billion. Ken Griffin’s Citadel Investment Group is the leading position holder in AT&T Inc. (NYSE:T), with 43.7 million shares worth over $1 billion.
Here is what Weitz Investment Management Hickory Fund has to say about AT&T Inc. (NYSE:T) in its Q4 2021 investor letter:
“After several quarters of pandemic-induced outsized growth, new broadband connection growth has slowed for U.S. cable operators. This slower growth has coincided with a renewed push by competitors like Verizon and AT&T to offer high-speed data (either via wireless connections or by building new fiber-optic networks).”
Click to continue reading and see 5 Favorite Stocks of Billionaire Izzy Englander.
Suggested articles:
10 Best Stocks to Buy Now According to Billionaire David Harding 10 Finance Stocks to Buy Today According to George Soros' Soros Fund Management 7 Best Stocks to Buy Now According to Bill Ackman
Disclosure: None. 10 Favorite Stocks of Billionaire Izzy Englander is originally published on Insider Monkey.
- 10 Best Vanguard ETFs to Invest In
Mar 9, 2022
In this article, we discuss 10 best Vanguard ETFs to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Vanguard ETFs to Invest In.
The Vanguard Group is a Pennsylvania-based investment advisor that is the one of the largest global providers of mutual funds and exchange-traded funds, in addition to specializing in brokerage services, asset management, and sub-advisory services. The Vanguard Group manages the long-term investment goals of its clients, helping individuals, institutions, and financial advisors navigate retirement and personal investments.
According to Bloomberg, The Vanguard Group was leading the ETF space that is valued at $6.8 trillion, and Vanguard exchange traded funds have already absorbed approximately $58 billion in 2022, which surpasses 2,817 competing funds combined. BlackRock has been the largest ETF provider since 2003, but with Vanguard’s record $328 billion haul in 2021, it is set to surpass BlackRock as the leading ETF manager over the course of the next two years.
Investing in exchange traded funds allows investors sufficient exposure, especially when they cannot afford individual stocks for a diversified portfolio. Some of the most notable companies that prominent Vanguard ETFs hold in their portfolios include Microsoft Corporation (NASDAQ:MSFT), Pfizer Inc. (NYSE:PFE), and Visa Inc. (NYSE:V).
Image by Sergei Tokmakov Terms.Law from Pixabay
Our Methodology
We selected prominent Vanguard ETFs, ensuring to select diversified underlying benchmarks, to provide potential investors with a well rounded outlook of different ETFs. We also made sure that the chosen exchange traded funds held quality stocks that are popular with elite hedge funds.
Best Vanguard ETFs to Invest In
10. Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI)
Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI) is an exchange traded fund that tracks the performance of the CRSP US Total Market Index. Following a passively managed strategy, the ETF invests in large, mid, and small-cap securities that include a diversified mix of growth and value stocks.
Story continues
Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI) holds a total of 4,136 stocks as of January 31, 2022, and the net assets of the fund are $1.3 trillion. With a top ten holdings concentration of 25.1%, the biggest holding of Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI) is Apple Inc. (NASDAQ:AAPL), a multinational American tech firm that manufactures and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Apple Inc. (NASDAQ:AAPL)’s move to ban the sales of its products in Russia is expected to only push the tech boycott tide even further. The stock gained almost 37% over the last 12 months.
Elite hedge funds are exceedingly bullish on Apple Inc. (NASDAQ:AAPL). According to the fourth quarter database of Insider Monkey, 134 hedge funds were bullish on Apple Inc. (NASDAQ:AAPL), up from 120 funds in the prior quarter. The total stakes held in Q4 amounted to $186 billion. Warren Buffett’s Berkshire Hathaway is the biggest shareholder of the company, with more than 887 million shares worth $157.5 billion.
In addition to Microsoft Corporation (NASDAQ:MSFT), Pfizer Inc. (NYSE:PFE), and Visa Inc. (NYSE:V), elite investors are piling into Apple Inc. (NASDAQ:AAPL).
Here is what Alger Spectra Fund has to say about Apple Inc. (NASDAQ:AAPL) in its Q4 2021 investor letter:
“Apple is a leading technology provider in telecommunications, computing and services. Apple’s iOS operating system is the company’s unique intellectual property and competitive strength. This software drives tight engagement with consumers and enterprises, fostering the growing purchases of high-margin services like music, apps and Apple Pay. Apple’s quarterly earnings exceeded street estimates on strong margin realization driven by a sales mix of more profitable services. The margin strength was even more impressive given significantly higher freight costs and supply constraints that prevented approximately $6 billion in revenue realization.”
9. Vanguard S&P 500 ETF (NYSE:VOO)
Vanguard S&P 500 ETF (NYSE:VOO) invests in S&P 500 constituents, closely mirroring the returns of the S&P 500 Index, allowing investors exposure to the biggest U.S. companies. Large-cap benchmark ETFs attracted the greatest investor inflows for February. On March 1, Vanguard S&P 500 ETF (NYSE:VOO), with $237.34 billion in assets under management, attracted $15.28 billion of new money, leading all ETFs.
Vanguard S&P 500 ETF (NYSE:VOO) holds 507 stocks in its portfolio, and the total net assets amounted to $816.6 billion. With the top ten holdings comprising 30.1% of the total investments, Microsoft Corporation (NASDAQ:MSFT) is a notable stock held by Vanguard S&P 500 ETF (NYSE:VOO).
Microsoft Corporation (NASDAQ:MSFT) on March 2 announced that it has received clearance from the U.K.'s Competition and Markets Authority over its Nuance Communications, Inc. (NASDAQ:NUAN) deal, marking the last approval the tech giant needed. Microsoft Corporation (NASDAQ:MSFT) shares were higher in premarket, gaining slightly more than 0.5% to $296.73, while Nuance rose to $55.97 after the announcement.
In the fourth quarter of 2021, 262 hedge funds were bullish on Microsoft Corporation (NASDAQ:MSFT), with combined stakes amounting to $75.6 billion, compared to 250 funds in the preceding quarter, holding total stakes worth $65.8 billion. Fisher Asset Management held the leading stake in Microsoft Corporation (NASDAQ:MSFT), with 26.8 million shares worth over $9 billion.
Here is what Alger Spectra Fund has to say about Microsoft Corporation (NASDAQ:MSFT) in its Q4 2021 investor letter:
“Class A shares of the Alger Spectra Fund underperformed the Russell 3000 Growth Index during the fourth quarter of 2021. Microsoft Corp. was among the top contributors to performance. Microsoft is a Positive Dynamic Change beneficiary of corporate America’s transformative digitization. Microsoft’s CEO believes technology spending as a percent of GDP is likely to jump from about 5% today to 10% in a few years and that Microsoft will continue to take market share Microsoft Corporation (NASDAQ:MSFT)’s enterprise cloud product, Azure, is rapidly growing and accruing market share. Microsoft Corporation (NASDAQ:MSFT) reported that Azure grew 50% in the past quarter. This high unit volume growth is a primary driver of the company’s higher share price, but strong operating execution has enabled margin expansion that has also helped to increase forward earnings estimates. We believe Microsoft Corporation (NASDAQ:MSFT)’s subscription-based software offerings and cloud computing services have a durable growth profile because they enhance customers’ growth initiatives and help them to diminish costs. Additionally, investors appreciate Microsoft’s strong free cash flow generation and its return of cash to shareholders in the form of dividends and share repurchases.”
8. Vanguard Russell 2000 Index Fund ETF Shares (NASDAQ:VTWO)
Vanguard Russell 2000 Index Fund ETF Shares (NASDAQ:VTWO) mirrors the performance of the Russell 2000 Index, which consists of small-cap U.S. companies. As of December 31, 2021, Vanguard Russell 2000 Index Fund ETF Shares (NASDAQ:VTWO)’s 1-year returns came in at 14.81%, compared to the Russell 2000 Index, which returned 14.82% over the same period.
On December 15, Vanguard Russell 2000 Index Fund ETF Shares (NASDAQ:VTWO) declared a quarterly distribution of $0.4745, which was paid on December 21. As of January 31, Vanguard Russell 2000 Index Fund ETF Shares (NASDAQ:VTWO) holds 2081 stocks in its portfolio, with total net assets amounting to $6.9 billion.
A major underlying holding of the ETF is Ovintiv Inc. (NYSE:OVV), a Colorado-based company that explores and markets natural gas, oil, and natural gas liquids, with the company’s primary reserves based in Texas, Oklahoma, British Columbia, and Alberta. Ovintiv Inc. (NYSE:OVV)’s revenue for the fourth quarter jumped 118.52% year-over-year to $3.34 billion, topping market consensus by $1.38 billion.
Among the hedge funds tracked by Insider Monkey, 44 hedge funds held long positions in Ovintiv Inc. (NYSE:OVV) at the end of December 2021, owning combined stakes of more than $1 billion. Marshall Wace LLP held the biggest position in the company, with shares worth $132.75 million.
Here is what Miller Value Partners Opportunity Equity has to say about Ovintiv Inc. (NYSE:OVV) in its Q4 2021 investor letter:
“The outlook for high multiple favorites depends to a great degree on interest rates. Warren Buffett likened interest rates to the force of gravity for asset prices. At current low levels, high valuations on long-duration assets can be justified. If interest rates move up, the adjustment will be painful. Market action early in the new year, with the swift moves up in interest rates and down in the Nasdaq, offers a taste of the medicine.
We underwrite all our names to have sufficient upside even if risk-free rates move up to 3% (a scenario, not a forecast!). As we evaluate the opportunity set, we find more attractive prospects in the classic value names. We often hear that people think value investing is dead, which only strengthens our conviction. Our gross exposure to classic value has risen from 44% a year ago to 62% currently.
One new name that illustrates the potential we see is Ovintiv (OVV), an oil and gas producer. We’ve seen a huge shift in the industry away from growth towards returns on capital, cash generation, and capacity discipline. OVV exemplifies the change.
OVV’s new CEO Brendan McCracken says: “We are at the forefront of driving innovation to produce oil and gas from shale both profitably and sustainably. We will generate superior returns and free cash flow by continuously improving capital efficiency and expanding margins while driving down emissions. We will deliver that value to our shareholders through disciplined capital allocation.”
Based on crude at $65 (well below the current $83.82 as of 1/14/22), the company guides to free cash flow generation of $11B over the next 5 years and $21B in the next 10 years. The company’s market cap is currently $10B and its enterprise value is $16B. It’s returning a significant portion of the capital to shareholders. If crude averages $70 in 2022, the company will return $700M to shareholders (in addition to paying down a significant amount of debt), which implies a yield of 7% at the current $39.53 price. In other words, there’s a good shot the company will return nearly its entire market cap to shareholders over the next 5 years.”
7. Vanguard Total World Stock Index Fund ETF Shares (NYSE:VT)
Vanguard Total World Stock Index Fund ETF Shares (NYSE:VT) is an exchange traded fund that invests in foreign and U.S. stocks, with a primary focus on emerging markets, Europe, Pacific, the Middle East, and North America. Vanguard Total World Stock Index Fund ETF Shares (NYSE:VT) declared on December 20 a quarterly distribution of $0.7850, which was paid to shareholders on December 23.
Vanguard Total World Stock Index Fund ETF Shares (NYSE:VT) tracks the performance of the FTSE Global All Cap Index, and the ETF has high potential for growth, but also exposes investors to high risk. As of January 31, 2022, the ETF holds 9,350 stocks in its portfolio, and the net assets equal $34.1 billion.
A major underlying security in Vanguard Total World Stock Index Fund ETF Shares (NYSE:VT)’s portfolio is Alphabet Inc. (NASDAQ:GOOG). The tech company agreed to buy cybersecurity firm Mandiant, Inc. (NASDAQ:MNDT) on March 8 for $23 per share in cash. The total value of the all-cash deal is $5.4 billion, and Alphabet Inc. (NASDAQ:GOOG) was competing with Microsoft Corporation (NASDAQ:MSFT) for the cybersecurity firm, though it reportedly walked away from the deal.
TCI Fund Management is the largest shareholder of Alphabet Inc. (NASDAQ:GOOG), with almost 3 million shares worth $8.5 billion. Overall, the fourth quarter database of Insider Monkey suggested that 158 hedge funds were long Alphabet Inc. (NASDAQ:GOOG), up from 156 funds in the quarter earlier.
Here is what Harding Loevner Global Equity Fund has to say about Alphabet Inc. (NASDAQ:GOOG) in its Q4 2021 investor letter:
“In a quarter that saw Alphabet’s Al-driven protein modeler win Science magazine’s “Breakthrough of the Year,” we also focused on a pair of companies putting somewhat less cutting-edge healthcare technology to lucrative use.
The one region where the style headwinds didn’t slow us at all was the US, where the portfolio’s holdings outperformed a very strong market. Good relative performance within the US was amplified by our hefty allocation there, which for most of the year remained close to the 65% ceiling of our risk guidelines, despite our trimming exposure to several US holdings as their valuations climbed. The positive contributors included Google parent Alphabet, up strongly on the year, thanks to a solid recovery in its core advertising business and ongoing progress on its cloud computing offerings.”
6. Vanguard Mid-Cap Index Fund ETF Shares (NYSE:VO)
Vanguard Mid-Cap Index Fund ETF Shares (NYSE:VO) is an exchange traded fund that mirrors the performance of the CRSP US Mid Cap Index, a benchmark that measures the investment return of mid-cap stocks, following a passively managed, full-replication approach. On December 23, Vanguard Mid-Cap Index Fund ETF Shares (NYSE:VO) declared a quarterly distribution of $0.9203, which was paid on December 30.
As of January 31, the ETF owns 371 stocks in its portfolio, with total net assets amounting to $155.7 billion. The largest holding in the portfolio of Vanguard Mid-Cap Index Fund ETF Shares (NYSE:VO) is Pioneer Natural Resources Company (NYSE:PXD), a Texas-based company that operates as an independent oil and gas company in the United States, producing oil, natural gas liquids, and gas.
Piper Sandler analyst Mark Lear raised the price target on Pioneer Natural Resources Company (NYSE:PXD) to $274 from $256 and kept an Overweight rating on the shares. According to the analyst, the exploration and production group is "passing the initial test on promised capital discipline" through price cycles and is broadly not accelerating activity levels in the current price environment.
Elite hedge funds hold large stakes in Pioneer Natural Resources Company (NYSE:PXD). In Q4 2021, 43 hedge funds were bullish on the stock, with collective stakes amounting to over $1 billion. Adage Capital Management held the biggest stake in the company, with 1.6 million shares worth $298.2 million.
Just like Microsoft Corporation (NASDAQ:MSFT), Pfizer Inc. (NYSE:PFE), and Visa Inc. (NYSE:V), Pioneer Natural Resources Company (NYSE:PXD) is a notable pick of institutional investors heading into 2022.
Here is what ClearBridge Investments Dividend Strategy has to say about Pioneer Natural Resources Company (NYSE:PXD) in its Q3 2021 investor letter:
“Over the last year we have also added a position in Pioneer Natural Resources, a best-in-class producer in the Permian Basin. We added Pioneer as we anticipated rising commodity prices and sought more direct leverage to that trend. Our overweight to energy has benefited our performance this year, in particular through the first half of the year, and we believe the sector, still less than 3% of the S&P 500, remains underinvested and attractive going forward.”
Click to continue reading and see 5 Best Vanguard ETFs to Invest In. Suggested articles:
10 Dividend Stocks with Over 10% Yield 10 Best Undervalued Stocks According to Hedge Funds 10 Nuclear Energy Stocks to Buy Now
Disclosure: None. 10 Best Vanguard ETFs to Invest In is originally published on Insider Monkey.
- Paul Tudor Jones Boosts 4 Holdings in 4th Quarter
Mar 8, 2022 · gurufocus.com
Paul Tudor Jones (Trades, Portfolio), founder and chief investment officer of Tudor Investment Group, disclosed in a regulatory 13F filing that its top trades during the fourth quarter of 2021 included boosts to his firm's holdings of IHS Markit Ltd. ( INFO , Financial), Nuance Communications Inc. ( NUAN , Financial), Apple Inc. ( AAPL , Financial) and Vonage Holdings Corp. ( VG , Financial).
- Nuance Communications Introduces Next-Generation Ambient AI Capabilities for PowerScribe Diagnostic Imaging Reporting Platform
Mar 8, 2022
AI-powered ambient intelligence technology in the radiology reading room helps radiologists easily turn free-form dictation into automatically organized, structured reports
BURLINGTON, Mass., March 8, 2022 /PRNewswire/ -- Nuance® Communications, Inc. announced an expansion of its next-generation ambient AI capabilities for diagnostic imaging. The expanded capabilities will include enhanced AI-powered reporting features in the Nuance PowerScribe platform that will empower radiologists to create highly accurate reports in less time and with more clinically valuable structured data.
The need for innovation in radiology interpretation and reporting is pressing, with more than one-third of imaging professionals reporting burnout. In some states, the population of patients in need of imaging services outpaces available radiologists by more than 25 percent, according to U.S. Census Data. This is driving a greater supply and demand imbalance in the radiology workforce.
As an industry leader and pioneer in speech and language understanding for over 20 years, Nuance is tackling this challenge head-on. With the Nuance PowerScribe platform, radiologists can focus on image interpretation instead of the mechanics of report creation. In Nuance PowerScribe One today, Ambient Mode uses advanced AI running in the Microsoft Azure cloud to enable radiologists to dictate in a completely free-form, unstructured, and narrative manner while in the background ambient AI technologies create a fully structured report. At the same time, ambient AI analyzes the report text while it is dictated looking for common errors, and whether clinical guidelines apply, to help the radiologist create higher quality reports. Later this year, ambient AI capabilities will also include advanced Auto Impression functionality that will automatically turn report findings into generated impression sections and follow-up recommendations, creating even more efficiencies for radiologists.
PowerScribe Ambient Mode uses the same breakthrough deep learning technology that powers the Nuance® Dragon® Ambient eXperience™ (DAX™), a solution that captures multi-party patient encounters and automatically creates clinical documentation thereby reducing administrative burdens on clinicians while simultaneously improving patient experience. PowerScribe Ambient Mode delivers a high degree of AI accuracy because of Nuance's decades of radiology reporting experience and its highly secure and trusted stewardship of radiology data spanning thousands of radiologists' interpretation styles, enabling high performance and native integration into the PowerScribe workflow.
Story continues
"Nuance's PowerScribe reporting solution has been the trusted diagnostic reporting solution for over 80% of all radiologists because of the AI-powered capabilities and benefits it delivers on a daily basis in a very demanding clinical environment," said Peter Durlach, Chief Strategy Officer at Nuance Communications. "With Ambient Mode, Nuance is bringing the next level of advanced AI to radiology reporting so that radiologists can gain greater efficiencies from auto structuring and auto impression functionality."
"Ensuring our radiologists have the best and most efficient diagnostic reporting system is critical to our organization's success and vital to patient care," said Keith J. Dreyer, DO, PhD, Chief Data Science Officer, and Vice Chairman of Radiology at Mass General Brigham. "We have relied on PowerScribe for almost two decades because of the consistent, high-level support, performance, and AI capabilities that we have received from Nuance, and we are extremely excited to leverage the full array of ambient functionality, including auto impression generation, so we can accelerate care delivery and help combat radiologist burnout."
To learn more about Nuance diagnostics solutions, including next-generation ambient capabilities for diagnostics, click here.
About Nuance Communications
Nuance Communications is a technology pioneer with market leadership in conversational AI and ambient intelligence. A full-service partner trusted by 77 percent of U.S. hospitals and 85 percent of the Fortune 100 companies worldwide, Nuance creates intuitive solutions that amplify people's ability to help others. Nuance is a Microsoft company.
Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.
Media Contact: Nuance Communications Caitlyn Keating
Tel : +1.781.565.8926
E-mail: caitlyn.keating@nuance.com Nuance Communications, Inc. logo (PRNewsfoto/Nuance Communications, Inc.) Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuance-communications-introduces-next-generation-ambient-ai-capabilities-for-powerscribe-diagnostic-imaging-reporting-platform-301497350.html
SOURCE Nuance Communications
